Radiopharmaceutical screening
-68Ga, 177Lu, 89Zr, 64Cu, 225Ac, 212Pb labeling synthesis
-Early screening stage pharmacokinetic, pharmacodynamic and toxicological studies

Radiopharmaceutical IND studies
-Radioactive drug ADME studies
-Radiopharmaceutical pharmacokinetic study
-Radiopharmaceutical tissue distribution studies and in vivo exposure dose estimation
-Radiopharmaceutical substance balance studies
-In vivo prototype ratio of radiopharmaceuticals

Pharmacodynamic studies of radiopharmaceuticals
-In vitro efficacy: cellular uptake, cellular endocytosis, cellular receptor binding;
-In vivo pharmacodynamics: PET/SPECT imaging;
-In vivo antitumor pharmacodynamics

Radiopharmaceutical toxicology studies
-Single/repeated extended toxicity studies of thermopharmaceuticals
-Safety of thermopharmaceutical preparations: hemolysis, irritation, allergy
-Radioactive drug delayed toxicity studies

Radiopharmaceutical clinical biological sample analysis
-Total radioactivity detection in clinical samples (gamma counter, liquid scintillation counter)
-Clinical plasma, urine prototype drug percentage assay (Radio-HPLC method)